Entera Bio (ENTX) Intangibles (2017 - 2021)
Entera Bio's (ENTX) quarterly Intangibles came in at $605000.0 in Q2 2021, little changed YoY from $605000.0 in Q2 2020, and little changed on a QoQ basis from $605000.0 in Q4 2020.
Entera Bio (ENTX) Intangibles (2017 - 2021) Analysis & Trends
Entera Bio (ENTX) has 5 years of Intangibles data on file, last reported at $605000.0 in Q2 2021.
- Quarterly Intangibles changed 0.0% year-over-year to $605000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $605000.0 (changed 0.0% YoY) and the FY2020 annual result came in at $605000.0, changed 0.0% from the prior year.
- Intangibles was little changed at $605000.0 in Q2 2021, from $605000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $654000.0 in Q4 2017 to a low of $605000.0 in Q4 2019.
- A 5-year average of $620833.3 and a median of $605000.0 in 2019 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2019 — Intangibles retreated 7.07% — and 2020, when it changed 0.0%.
- Tracing ENTX's Intangibles over 5 years: stood at $654000.0 in 2017, then slipped by 0.46% to $651000.0 in 2018, then decreased by 7.07% to $605000.0 in 2019, then changed by 0.0% to $605000.0 in 2020, then changed by 0.0% to $605000.0 in 2021.
- The last three Intangibles figures came in at $605000.0 (Q2 2021), $605000.0 (Q4 2020), and $605000.0 (Q2 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Entera Bio | 161.44 Mn | 150.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 605,000.00 |
| Dec 31, 2020 | 605,000.00 |
| Jun 30, 2020 | 605,000.00 |
| Dec 31, 2019 | 605,000.00 |
| Dec 31, 2018 | 651,000.00 |
| Dec 31, 2017 | 654,000.00 |